The global fight against malaria took a stride forward on Monday as Cameroon started the world’s first routine vaccine program against the mosquito-borne disease, although Reuters journalists witnessed few people in clinics receiving the shot. Around 40 years in the making, the
A one-size-fits-all flu vaccine could be on the horizon after scientists found an antibody that protects against several strains of the virus. The team from the University of Pittsburgh School of Medicine identified a class of antibodies previously unrecognised that can neutralise
New hope may be on the horizon for melanoma patients in the form of a novel skin cancer vaccine. This week, Moderna announced that its new vaccine has shown promising results in clinical trials. Among 157 patients with advanced melanoma, the vaccine
Each year, the U.S. Food and Drug Administration (FDA) approves hundreds of new drugs and therapeutic products for use by the American public. GoodRx Health, an American health care company and telemedicine platform, has compiled and published a list of some of
A statistician has been arrested in New Zealand for allegedly leaking health data connected to the rollout of the coronavirus vaccination. Barry Young, a former employee of New Zealand’s government health agency Te Whatu Ora, is accused of “unauthorised disclosure and misuse
Fewer U.S. health care workers are keeping up to date on their COVID-19 and flu vaccinations, according to two separate reports this week from the Centers for Disease Control and Prevention (CDC). For the first study, researchers pulled data from the CDC’s
The U.S. Food and Drug Administration (FDA) on Thursday announced its approval of Ixchiq, the first chikungunya vaccine. The vaccine, which is made by Valneva, is approved for anyone age 18 and older who has a risk of being exposed to the
The efficiency of the Oxford-AstraZeneca vaccine has been questioned after the COVID-19 jab was branded “defected” in a multi-million pound landmark legal case in High Court. The pharmaceutical firm is being sued by father of two Jamie Scott who suffered from brain
There are shortages of an RSV vaccine for infants due to supply issues. The Centers for Disease Control and Prevention (CDC) released a notice last week citing “limited availability” of the long-acting monoclonal antibody immunization Beyfortus (nirsevimab). The product is recommended by
Thus far, according to the outlet, animal trials for the vaccine have proven successful. Now, the final phase of the trial involves testing the vaccine on humans — which could begin as early as January of 2024. The so-called “cocaine vaccine” works